Natixis Advisors LLC grew its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI – Free Report) by 2.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 399,388 shares of the financial services provider’s stock after buying an additional 9,768 shares during the period. Natixis Advisors LLC owned 0.57% of Houlihan Lokey worth $63,111,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Opal Wealth Advisors LLC purchased a new stake in Houlihan Lokey in the second quarter worth about $26,000. Crewe Advisors LLC boosted its position in shares of Houlihan Lokey by 264.5% in the 2nd quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 164 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Houlihan Lokey in the 2nd quarter worth approximately $38,000. Wolff Wiese Magana LLC bought a new position in Houlihan Lokey during the 3rd quarter valued at approximately $38,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in Houlihan Lokey by 69.1% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 678 shares of the financial services provider’s stock valued at $91,000 after buying an additional 277 shares in the last quarter. 78.07% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, Director Gillian Beth Zucker sold 200 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $152.28, for a total value of $30,456.00. Following the transaction, the director now owns 6,801 shares of the company’s stock, valued at approximately $1,035,656.28. This trade represents a 2.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,600 shares of company stock valued at $249,860. Insiders own 23.68% of the company’s stock.
Houlihan Lokey Stock Up 0.0 %
Houlihan Lokey (NYSE:HLI – Get Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.15. The business had revenue of $574.96 million during the quarter, compared to analyst estimates of $537.93 million. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The company’s quarterly revenue was up 23.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.11 EPS. As a group, analysts expect that Houlihan Lokey, Inc. will post 5.79 earnings per share for the current year.
Houlihan Lokey Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Sunday, December 15th. Shareholders of record on Monday, December 2nd will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date of this dividend is Monday, December 2nd. Houlihan Lokey’s dividend payout ratio is 46.63%.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on HLI shares. Wells Fargo & Company assumed coverage on Houlihan Lokey in a research note on Thursday, September 12th. They issued an “underweight” rating and a $149.00 target price on the stock. Keefe, Bruyette & Woods reissued a “market perform” rating and set a $154.00 price objective (up from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. Morgan Stanley lifted their target price on shares of Houlihan Lokey from $146.00 to $163.00 and gave the stock an “equal weight” rating in a report on Monday, September 23rd. UBS Group upped their target price on shares of Houlihan Lokey from $170.00 to $190.00 and gave the stock a “buy” rating in a research note on Tuesday, October 8th. Finally, StockNews.com raised shares of Houlihan Lokey from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Houlihan Lokey presently has an average rating of “Hold” and an average target price of $157.00.
Get Our Latest Stock Analysis on HLI
Houlihan Lokey Company Profile
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
See Also
- Five stocks we like better than Houlihan Lokey
- Are Penny Stocks a Good Fit for Your Portfolio?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Stock Market Upgrades: What Are They?
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI – Free Report).
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.